Robin Deterding
Concepts (474)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Diseases, Interstitial | 36 | 2025 | 594 | 7.910 |
Why?
| Pulmonary Surfactant-Associated Protein C | 9 | 2023 | 45 | 2.350 |
Why?
| Neuroendocrine Cells | 9 | 2020 | 32 | 2.200 |
Why?
| Respiration Disorders | 5 | 2019 | 73 | 1.700 |
Why?
| Bronchoalveolar Lavage Fluid | 7 | 2019 | 642 | 1.620 |
Why?
| Hyperplasia | 12 | 2022 | 171 | 1.600 |
Why?
| Glycogen Storage Disease | 3 | 2021 | 19 | 1.490 |
Why?
| Lung | 30 | 2024 | 3925 | 1.260 |
Why?
| Idiopathic Pulmonary Fibrosis | 6 | 2024 | 618 | 1.250 |
Why?
| Infant | 44 | 2025 | 8994 | 1.110 |
Why?
| Child | 73 | 2025 | 20824 | 1.110 |
Why?
| Cystic Fibrosis | 7 | 2019 | 1061 | 0.980 |
Why?
| Child, Preschool | 40 | 2025 | 10457 | 0.950 |
Why?
| Proteomics | 6 | 2023 | 985 | 0.940 |
Why?
| Machine Learning | 2 | 2019 | 417 | 0.930 |
Why?
| Pediatrics | 8 | 2015 | 1060 | 0.900 |
Why?
| Tomography, X-Ray Computed | 17 | 2024 | 2530 | 0.840 |
Why?
| Oxygen Inhalation Therapy | 5 | 2019 | 146 | 0.810 |
Why?
| Mutation | 14 | 2024 | 3671 | 0.740 |
Why?
| Bronchiectasis | 3 | 2024 | 112 | 0.730 |
Why?
| Humans | 109 | 2025 | 128896 | 0.700 |
Why?
| Immunologic Techniques | 1 | 2019 | 39 | 0.680 |
Why?
| Biopsy | 15 | 2019 | 1093 | 0.630 |
Why?
| Allergy and Immunology | 1 | 2019 | 60 | 0.630 |
Why?
| Home Care Services | 2 | 2019 | 246 | 0.620 |
Why?
| Sleep Wake Disorders | 2 | 2020 | 246 | 0.620 |
Why?
| Nocturnal Myoclonus Syndrome | 1 | 2018 | 6 | 0.610 |
Why?
| Respiratory Distress Syndrome, Newborn | 2 | 2019 | 105 | 0.590 |
Why?
| Aptamers, Nucleotide | 1 | 2019 | 78 | 0.590 |
Why?
| Asthma | 3 | 2019 | 2258 | 0.560 |
Why?
| Respiratory Function Tests | 12 | 2024 | 596 | 0.560 |
Why?
| Lung Diseases | 8 | 2020 | 755 | 0.560 |
Why?
| Hypoxia | 4 | 2018 | 1070 | 0.560 |
Why?
| Deoxycytosine Nucleotides | 2 | 2007 | 11 | 0.520 |
Why?
| Uridine | 2 | 2007 | 29 | 0.520 |
Why?
| Male | 53 | 2025 | 63146 | 0.510 |
Why?
| Female | 52 | 2025 | 68162 | 0.490 |
Why?
| Pulmonary Alveoli | 7 | 2021 | 403 | 0.480 |
Why?
| Pulmonary Surfactants | 8 | 2013 | 108 | 0.470 |
Why?
| Hypertension, Pulmonary | 7 | 2024 | 1876 | 0.470 |
Why?
| Bronchiolitis Obliterans | 4 | 2024 | 71 | 0.460 |
Why?
| Clinical Clerkship | 6 | 2007 | 89 | 0.450 |
Why?
| Adolescent | 34 | 2025 | 20197 | 0.440 |
Why?
| Household Articles | 1 | 2014 | 26 | 0.440 |
Why?
| Respiration, Artificial | 4 | 2021 | 594 | 0.440 |
Why?
| Research | 2 | 2020 | 413 | 0.430 |
Why?
| Disinfectants | 1 | 2014 | 36 | 0.430 |
Why?
| Pulmonary Surfactant-Associated Protein B | 3 | 2010 | 5 | 0.430 |
Why?
| Retrospective Studies | 25 | 2024 | 14546 | 0.420 |
Why?
| Growth Substances | 6 | 2000 | 155 | 0.410 |
Why?
| Bronchiolitis | 1 | 2013 | 92 | 0.400 |
Why?
| Esophagoscopy | 3 | 2019 | 196 | 0.380 |
Why?
| Polyendocrinopathies, Autoimmune | 1 | 2011 | 18 | 0.380 |
Why?
| International Classification of Diseases | 1 | 2012 | 124 | 0.380 |
Why?
| Neurosecretory Systems | 3 | 2010 | 31 | 0.380 |
Why?
| ATP-Binding Cassette Transporters | 5 | 2014 | 128 | 0.380 |
Why?
| Program Development | 2 | 2018 | 360 | 0.370 |
Why?
| Humidity | 1 | 2011 | 50 | 0.360 |
Why?
| Infant, Newborn | 17 | 2019 | 5704 | 0.360 |
Why?
| Potassium Channels | 1 | 2011 | 139 | 0.360 |
Why?
| Fibroblast Growth Factors | 5 | 2000 | 171 | 0.350 |
Why?
| Dust | 1 | 2011 | 100 | 0.340 |
Why?
| Computer Simulation | 4 | 2018 | 943 | 0.340 |
Why?
| Education, Medical, Undergraduate | 3 | 2007 | 174 | 0.340 |
Why?
| Rare Diseases | 3 | 2020 | 102 | 0.340 |
Why?
| Inhalation Exposure | 1 | 2011 | 110 | 0.330 |
Why?
| Pulmonary Alveolar Proteinosis | 2 | 2023 | 17 | 0.330 |
Why?
| Problem-Based Learning | 4 | 2006 | 77 | 0.330 |
Why?
| Diagnosis, Differential | 6 | 2019 | 1435 | 0.330 |
Why?
| Purinergic P2 Receptor Agonists | 2 | 2007 | 4 | 0.320 |
Why?
| Hematopoietic Stem Cell Transplantation | 2 | 2024 | 576 | 0.310 |
Why?
| Immunologic Factors | 2 | 2011 | 227 | 0.300 |
Why?
| Eosinophilic Esophagitis | 3 | 2019 | 333 | 0.300 |
Why?
| Autoimmune Diseases | 3 | 2024 | 419 | 0.300 |
Why?
| Pulmonary Fibrosis | 2 | 2024 | 381 | 0.300 |
Why?
| Tomography | 2 | 2018 | 23 | 0.300 |
Why?
| Lung Injury | 1 | 2011 | 214 | 0.290 |
Why?
| Curriculum | 2 | 2007 | 925 | 0.280 |
Why?
| Case-Control Studies | 6 | 2019 | 3334 | 0.280 |
Why?
| Respiratory Tract Diseases | 2 | 2019 | 151 | 0.270 |
Why?
| Cytokines | 2 | 2019 | 1995 | 0.270 |
Why?
| Practice Guidelines as Topic | 4 | 2024 | 1523 | 0.270 |
Why?
| Gastrointestinal Diseases | 2 | 2018 | 197 | 0.260 |
Why?
| Pneumonia | 2 | 2019 | 612 | 0.250 |
Why?
| United States | 12 | 2025 | 13975 | 0.250 |
Why?
| Vital Capacity | 2 | 2024 | 285 | 0.250 |
Why?
| Genetic Testing | 2 | 2025 | 424 | 0.240 |
Why?
| Double-Blind Method | 3 | 2023 | 1858 | 0.240 |
Why?
| Disease Progression | 3 | 2024 | 2603 | 0.240 |
Why?
| Bronchodilator Agents | 1 | 2006 | 252 | 0.230 |
Why?
| Receptors, CCR2 | 1 | 2023 | 39 | 0.220 |
Why?
| Fibrosis | 2 | 2024 | 518 | 0.220 |
Why?
| Hernia, Diaphragmatic | 1 | 2003 | 69 | 0.220 |
Why?
| Deglutition | 1 | 2024 | 66 | 0.220 |
Why?
| Pleural Effusion | 1 | 2003 | 52 | 0.210 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 339 | 0.210 |
Why?
| Biomarkers | 5 | 2019 | 3874 | 0.210 |
Why?
| Severity of Illness Index | 4 | 2020 | 2767 | 0.200 |
Why?
| Thyroid Nuclear Factor 1 | 3 | 2019 | 15 | 0.200 |
Why?
| Bronchoscopy | 3 | 2018 | 215 | 0.190 |
Why?
| Self-Evaluation Programs | 2 | 1999 | 6 | 0.190 |
Why?
| Arthritis, Juvenile | 2 | 2019 | 54 | 0.190 |
Why?
| Endoscopy, Gastrointestinal | 1 | 2024 | 215 | 0.190 |
Why?
| Education, Medical | 1 | 2005 | 241 | 0.190 |
Why?
| Heart Defects, Congenital | 3 | 2018 | 752 | 0.190 |
Why?
| Epstein-Barr Virus Infections | 1 | 2022 | 93 | 0.180 |
Why?
| Immunocompromised Host | 2 | 2015 | 198 | 0.180 |
Why?
| Protein C | 1 | 2021 | 45 | 0.180 |
Why?
| Stevens-Johnson Syndrome | 1 | 2021 | 38 | 0.180 |
Why?
| Indoles | 1 | 2024 | 378 | 0.180 |
Why?
| Thinking | 1 | 2001 | 57 | 0.170 |
Why?
| Pulmonary Medicine | 2 | 2019 | 79 | 0.170 |
Why?
| Immunologic Deficiency Syndromes | 1 | 2000 | 64 | 0.170 |
Why?
| Proteolipids | 2 | 2000 | 30 | 0.170 |
Why?
| Foundations | 2 | 2020 | 24 | 0.170 |
Why?
| Heart Diseases | 1 | 2023 | 356 | 0.160 |
Why?
| Athetosis | 1 | 2019 | 7 | 0.160 |
Why?
| Respiratory Rate | 1 | 2019 | 20 | 0.160 |
Why?
| Chorea | 1 | 2019 | 11 | 0.160 |
Why?
| Congenital Hypothyroidism | 1 | 2019 | 11 | 0.160 |
Why?
| Infant, Newborn, Diseases | 1 | 2001 | 108 | 0.160 |
Why?
| Genetic Predisposition to Disease | 3 | 2019 | 2270 | 0.160 |
Why?
| Otorhinolaryngologic Diseases | 1 | 2019 | 14 | 0.160 |
Why?
| Digestive System Diseases | 1 | 2019 | 25 | 0.160 |
Why?
| User-Computer Interface | 3 | 2006 | 147 | 0.160 |
Why?
| Societies | 1 | 2019 | 37 | 0.160 |
Why?
| Registries | 2 | 2025 | 1916 | 0.160 |
Why?
| Preceptorship | 1 | 1999 | 72 | 0.150 |
Why?
| Oximetry | 1 | 2019 | 86 | 0.150 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2019 | 98 | 0.150 |
Why?
| Educational Measurement | 1 | 2001 | 259 | 0.150 |
Why?
| Air | 1 | 2018 | 36 | 0.150 |
Why?
| Colorado | 6 | 2019 | 4443 | 0.150 |
Why?
| Bronchi | 2 | 2015 | 253 | 0.150 |
Why?
| Esophageal Mucosa | 1 | 2018 | 20 | 0.150 |
Why?
| Virtual Reality | 1 | 2019 | 51 | 0.150 |
Why?
| Adult | 14 | 2024 | 35361 | 0.150 |
Why?
| Models, Anatomic | 1 | 2018 | 94 | 0.150 |
Why?
| Fibroblast Growth Factor 1 | 2 | 1996 | 12 | 0.140 |
Why?
| Pneumonia, Lipid | 1 | 2017 | 3 | 0.140 |
Why?
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 108 | 0.140 |
Why?
| Radiography | 3 | 2013 | 863 | 0.140 |
Why?
| Research Design | 2 | 2023 | 1038 | 0.140 |
Why?
| Respiration | 1 | 2018 | 191 | 0.140 |
Why?
| Arteriovenous Anastomosis | 1 | 2017 | 13 | 0.140 |
Why?
| Bronchial Arteries | 1 | 2017 | 12 | 0.140 |
Why?
| Polysomnography | 1 | 2018 | 155 | 0.140 |
Why?
| Autophagy | 2 | 2022 | 263 | 0.140 |
Why?
| Respiratory Sounds | 2 | 2010 | 121 | 0.140 |
Why?
| Lymphocytes | 1 | 2019 | 369 | 0.140 |
Why?
| Prognosis | 6 | 2024 | 3787 | 0.140 |
Why?
| Down Syndrome | 1 | 2023 | 454 | 0.140 |
Why?
| Internal Medicine | 1 | 1999 | 249 | 0.130 |
Why?
| Membrane Proteins | 2 | 2022 | 1100 | 0.130 |
Why?
| Gastrostomy | 1 | 2018 | 113 | 0.130 |
Why?
| Gastroesophageal Reflux | 2 | 2015 | 240 | 0.130 |
Why?
| Disease Management | 3 | 2019 | 594 | 0.130 |
Why?
| Delivery of Health Care, Integrated | 1 | 2019 | 248 | 0.130 |
Why?
| Clinical Competence | 3 | 2018 | 1020 | 0.130 |
Why?
| Pulmonary Artery | 2 | 2024 | 1091 | 0.130 |
Why?
| Lung Transplantation | 2 | 2015 | 276 | 0.130 |
Why?
| Mutation, Missense | 2 | 2014 | 319 | 0.130 |
Why?
| Young Adult | 8 | 2019 | 12286 | 0.120 |
Why?
| Bleomycin | 1 | 1997 | 241 | 0.120 |
Why?
| Esophageal Atresia | 1 | 2015 | 25 | 0.120 |
Why?
| Pulmonary Surgical Procedures | 1 | 2015 | 8 | 0.120 |
Why?
| Natural Orifice Endoscopic Surgery | 1 | 2015 | 27 | 0.120 |
Why?
| Comorbidity | 1 | 2020 | 1542 | 0.120 |
Why?
| Tracheoesophageal Fistula | 1 | 2015 | 33 | 0.120 |
Why?
| Thyroid Gland | 1 | 2015 | 94 | 0.120 |
Why?
| Imaging, Three-Dimensional | 2 | 2017 | 559 | 0.120 |
Why?
| Pregnancy Trimester, First | 1 | 2015 | 133 | 0.120 |
Why?
| Patient Satisfaction | 2 | 2019 | 639 | 0.120 |
Why?
| Gestational Age | 1 | 2018 | 857 | 0.120 |
Why?
| Family Practice | 1 | 1999 | 451 | 0.120 |
Why?
| Heart Rate | 1 | 2019 | 807 | 0.120 |
Why?
| Clinical Trials as Topic | 1 | 2019 | 1002 | 0.120 |
Why?
| Adrenal Cortex Hormones | 1 | 2018 | 525 | 0.120 |
Why?
| Pluripotent Stem Cells | 1 | 2015 | 76 | 0.120 |
Why?
| Patient Care Team | 2 | 2018 | 605 | 0.120 |
Why?
| Delayed Diagnosis | 1 | 2015 | 81 | 0.120 |
Why?
| Angiography | 1 | 2015 | 199 | 0.120 |
Why?
| Genetic Diseases, Inborn | 1 | 2014 | 38 | 0.120 |
Why?
| Phenotype | 3 | 2018 | 3059 | 0.110 |
Why?
| Chest Tubes | 1 | 2014 | 29 | 0.110 |
Why?
| Forced Expiratory Volume | 3 | 2024 | 509 | 0.110 |
Why?
| Thoracic Surgery, Video-Assisted | 1 | 2014 | 43 | 0.110 |
Why?
| Cell Differentiation | 3 | 2015 | 1854 | 0.110 |
Why?
| Regeneration | 1 | 2015 | 177 | 0.110 |
Why?
| Deglutition Disorders | 1 | 2015 | 129 | 0.110 |
Why?
| Societies, Medical | 2 | 2019 | 760 | 0.110 |
Why?
| Electric Impedance | 3 | 2018 | 102 | 0.110 |
Why?
| Ambulatory Care | 1 | 2018 | 509 | 0.110 |
Why?
| Blood Proteins | 1 | 2015 | 233 | 0.110 |
Why?
| Abnormalities, Multiple | 1 | 2015 | 178 | 0.110 |
Why?
| Diagnostic Techniques, Respiratory System | 1 | 2013 | 5 | 0.110 |
Why?
| Image Processing, Computer-Assisted | 1 | 2018 | 739 | 0.110 |
Why?
| Airway Obstruction | 1 | 2015 | 157 | 0.110 |
Why?
| Treatment Outcome | 6 | 2015 | 10239 | 0.110 |
Why?
| DNA Mutational Analysis | 2 | 2013 | 391 | 0.110 |
Why?
| Homozygote | 1 | 2013 | 192 | 0.110 |
Why?
| Autoimmunity | 1 | 2019 | 861 | 0.110 |
Why?
| Software | 1 | 1998 | 611 | 0.110 |
Why?
| Pedigree | 2 | 2013 | 491 | 0.100 |
Why?
| Evidence-Based Medicine | 1 | 2017 | 729 | 0.100 |
Why?
| Follow-Up Studies | 4 | 2019 | 4917 | 0.100 |
Why?
| Glycoproteins | 2 | 2000 | 340 | 0.100 |
Why?
| Schools, Medical | 2 | 2007 | 128 | 0.100 |
Why?
| Device Removal | 1 | 2014 | 140 | 0.100 |
Why?
| Mucin-5B | 1 | 2015 | 217 | 0.100 |
Why?
| Critical Care | 1 | 2017 | 547 | 0.100 |
Why?
| Plethysmography | 1 | 2012 | 109 | 0.100 |
Why?
| Autoantibodies | 3 | 2019 | 1460 | 0.100 |
Why?
| Familial Primary Pulmonary Hypertension | 2 | 2024 | 197 | 0.100 |
Why?
| Fibroblast Growth Factor 7 | 5 | 2000 | 16 | 0.100 |
Why?
| Fibroblast Growth Factor 10 | 5 | 2000 | 24 | 0.100 |
Why?
| World Health Organization | 1 | 2012 | 106 | 0.100 |
Why?
| Leukocytes | 1 | 2013 | 301 | 0.100 |
Why?
| Spirometry | 1 | 2012 | 252 | 0.100 |
Why?
| Premature Birth | 1 | 2015 | 313 | 0.100 |
Why?
| Models, Statistical | 1 | 2015 | 626 | 0.100 |
Why?
| Internship and Residency | 2 | 2018 | 1052 | 0.090 |
Why?
| Hydrocortisone | 1 | 1994 | 300 | 0.090 |
Why?
| Genetic Counseling | 2 | 2015 | 72 | 0.090 |
Why?
| Cardiac Catheterization | 1 | 2015 | 583 | 0.090 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 85 | 0.090 |
Why?
| Bronchoalveolar Lavage | 3 | 2007 | 92 | 0.090 |
Why?
| Physicians | 1 | 2019 | 846 | 0.090 |
Why?
| Bromhexine | 1 | 2010 | 1 | 0.090 |
Why?
| Rats, Sprague-Dawley | 5 | 1997 | 2308 | 0.090 |
Why?
| Laryngeal Diseases | 1 | 2011 | 26 | 0.090 |
Why?
| Granulomatosis with Polyangiitis | 1 | 2011 | 43 | 0.090 |
Why?
| Rats | 8 | 2000 | 5236 | 0.090 |
Why?
| Epithelial Cells | 4 | 2015 | 1059 | 0.090 |
Why?
| Syndrome | 1 | 2011 | 342 | 0.090 |
Why?
| Rituximab | 1 | 2011 | 161 | 0.090 |
Why?
| Alveolitis, Extrinsic Allergic | 1 | 2011 | 96 | 0.090 |
Why?
| Endoscopy, Digestive System | 2 | 2024 | 120 | 0.090 |
Why?
| Intestinal Mucosa | 1 | 2015 | 569 | 0.090 |
Why?
| Nuclear Proteins | 2 | 2013 | 644 | 0.090 |
Why?
| Referral and Consultation | 1 | 2015 | 727 | 0.080 |
Why?
| Diagnostic Imaging | 2 | 2015 | 327 | 0.080 |
Why?
| Uniparental Disomy | 1 | 2009 | 7 | 0.080 |
Why?
| Microscopy, Electron | 3 | 2013 | 417 | 0.080 |
Why?
| Anti-Bacterial Agents | 2 | 2013 | 1701 | 0.080 |
Why?
| Uteroglobin | 2 | 2000 | 21 | 0.080 |
Why?
| Esophagus | 2 | 2024 | 253 | 0.080 |
Why?
| Mucin-1 | 1 | 2009 | 20 | 0.080 |
Why?
| Lipid Metabolism, Inborn Errors | 1 | 2009 | 17 | 0.080 |
Why?
| Body Mass Index | 1 | 2017 | 2244 | 0.080 |
Why?
| Neutrophils | 1 | 2013 | 1203 | 0.070 |
Why?
| Cell Division | 4 | 2000 | 800 | 0.070 |
Why?
| DNA | 2 | 2013 | 1406 | 0.070 |
Why?
| Cytogenetic Analysis | 1 | 2007 | 34 | 0.070 |
Why?
| Lung Volume Measurements | 1 | 2007 | 44 | 0.070 |
Why?
| Medical History Taking | 2 | 2005 | 119 | 0.070 |
Why?
| Nebulizers and Vaporizers | 1 | 2007 | 82 | 0.070 |
Why?
| Transcription Factors | 2 | 2013 | 1634 | 0.070 |
Why?
| Respiratory Tract Infections | 1 | 2011 | 372 | 0.070 |
Why?
| Logistic Models | 3 | 2015 | 1963 | 0.070 |
Why?
| Delphi Technique | 2 | 2018 | 219 | 0.070 |
Why?
| DNA, Bacterial | 1 | 2007 | 324 | 0.060 |
Why?
| Cough | 1 | 2007 | 118 | 0.060 |
Why?
| Consensus | 2 | 2020 | 644 | 0.060 |
Why?
| Computer-Assisted Instruction | 1 | 2006 | 60 | 0.060 |
Why?
| Animals | 12 | 2019 | 34628 | 0.060 |
Why?
| Cross-Sectional Studies | 2 | 2015 | 5032 | 0.060 |
Why?
| Receptors, Purinergic P2Y2 | 1 | 2005 | 6 | 0.060 |
Why?
| Prospective Studies | 4 | 2023 | 7060 | 0.060 |
Why?
| Administration, Inhalation | 2 | 2005 | 675 | 0.060 |
Why?
| Respiratory Mucosa | 2 | 2014 | 313 | 0.060 |
Why?
| Intraoperative Period | 2 | 2015 | 53 | 0.060 |
Why?
| Age Distribution | 1 | 2005 | 376 | 0.060 |
Why?
| Faculty, Medical | 1 | 2007 | 263 | 0.060 |
Why?
| Teaching | 1 | 2006 | 209 | 0.060 |
Why?
| Program Evaluation | 2 | 2019 | 868 | 0.060 |
Why?
| Age of Onset | 1 | 2005 | 494 | 0.050 |
Why?
| Pulmonary Veno-Occlusive Disease | 1 | 2003 | 12 | 0.050 |
Why?
| T-Box Domain Proteins | 1 | 2024 | 95 | 0.050 |
Why?
| Patient Simulation | 1 | 2003 | 34 | 0.050 |
Why?
| Cohort Studies | 3 | 2023 | 5394 | 0.050 |
Why?
| Autophagy-Related Proteins | 1 | 2022 | 41 | 0.050 |
Why?
| Methylprednisolone | 2 | 2013 | 83 | 0.050 |
Why?
| Macrophages, Alveolar | 2 | 2023 | 389 | 0.050 |
Why?
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2022 | 49 | 0.050 |
Why?
| Terminology as Topic | 2 | 2018 | 204 | 0.050 |
Why?
| Neuroblastoma | 1 | 2003 | 152 | 0.050 |
Why?
| Bayes Theorem | 1 | 2024 | 367 | 0.050 |
Why?
| Bone Marrow Transplantation | 1 | 2003 | 267 | 0.050 |
Why?
| Data Collection | 1 | 2005 | 652 | 0.050 |
Why?
| Vesicular Transport Proteins | 1 | 2022 | 87 | 0.050 |
Why?
| Genotype | 2 | 2018 | 1834 | 0.050 |
Why?
| Herpesvirus 4, Human | 1 | 2022 | 153 | 0.050 |
Why?
| Cross-Cultural Comparison | 1 | 2001 | 80 | 0.050 |
Why?
| Disease Models, Animal | 3 | 2019 | 3994 | 0.050 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 228 | 0.050 |
Why?
| Bacteria | 1 | 2007 | 812 | 0.050 |
Why?
| RNA, Messenger | 4 | 2000 | 2700 | 0.040 |
Why?
| Surface-Active Agents | 1 | 2021 | 82 | 0.040 |
Why?
| Neoplasms | 1 | 2015 | 2426 | 0.040 |
Why?
| Group Processes | 1 | 2001 | 55 | 0.040 |
Why?
| Combined Modality Therapy | 2 | 2015 | 1213 | 0.040 |
Why?
| Models, Educational | 1 | 2001 | 83 | 0.040 |
Why?
| Pulmonary Surfactant-Associated Proteins | 2 | 2000 | 10 | 0.040 |
Why?
| Immunohistochemistry | 2 | 2015 | 1694 | 0.040 |
Why?
| Developing Countries | 1 | 2001 | 278 | 0.040 |
Why?
| Pemphigus | 1 | 1999 | 9 | 0.040 |
Why?
| Leukocytes, Mononuclear | 1 | 2022 | 543 | 0.040 |
Why?
| Paraneoplastic Syndromes | 1 | 1999 | 12 | 0.040 |
Why?
| Heart | 1 | 2023 | 650 | 0.040 |
Why?
| Incidence | 2 | 2019 | 2634 | 0.040 |
Why?
| Speech-Language Pathology | 1 | 2019 | 19 | 0.040 |
Why?
| Anti-Inflammatory Agents | 2 | 2013 | 468 | 0.040 |
Why?
| Pulmonary Surfactant-Associated Protein D | 2 | 2000 | 30 | 0.040 |
Why?
| Esophageal pH Monitoring | 1 | 2018 | 23 | 0.040 |
Why?
| Survival Rate | 2 | 2019 | 1884 | 0.040 |
Why?
| Hospital Information Systems | 1 | 1998 | 14 | 0.040 |
Why?
| Formative Feedback | 1 | 2018 | 26 | 0.040 |
Why?
| Computer Communication Networks | 1 | 1998 | 32 | 0.040 |
Why?
| Students, Medical | 1 | 2002 | 305 | 0.040 |
Why?
| NF-kappa B | 1 | 2022 | 685 | 0.040 |
Why?
| Alveolar Epithelial Cells | 1 | 2019 | 106 | 0.040 |
Why?
| Efficiency, Organizational | 1 | 2019 | 131 | 0.040 |
Why?
| Interdisciplinary Research | 1 | 2018 | 26 | 0.040 |
Why?
| Otolaryngology | 1 | 2019 | 84 | 0.040 |
Why?
| Drug Antagonism | 1 | 1997 | 10 | 0.040 |
Why?
| Fundoplication | 1 | 1997 | 54 | 0.040 |
Why?
| Hydroxyproline | 1 | 1997 | 22 | 0.040 |
Why?
| Macrophage Activation Syndrome | 1 | 2017 | 21 | 0.040 |
Why?
| Information Storage and Retrieval | 1 | 1998 | 106 | 0.040 |
Why?
| Receptor Protein-Tyrosine Kinases | 2 | 1996 | 234 | 0.030 |
Why?
| Early Diagnosis | 1 | 2018 | 232 | 0.030 |
Why?
| Gene Expression | 3 | 2000 | 1476 | 0.030 |
Why?
| Review Literature as Topic | 1 | 2017 | 66 | 0.030 |
Why?
| Hydrochloric Acid | 1 | 1996 | 9 | 0.030 |
Why?
| Cholera Toxin | 1 | 1996 | 29 | 0.030 |
Why?
| Trachea | 1 | 2018 | 228 | 0.030 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 1996 | 24 | 0.030 |
Why?
| Gastroenterology | 1 | 2019 | 177 | 0.030 |
Why?
| Endoplasmic Reticulum | 1 | 2019 | 256 | 0.030 |
Why?
| Ambulatory Care Facilities | 1 | 2018 | 226 | 0.030 |
Why?
| Receptors, Fibroblast Growth Factor | 1 | 1996 | 65 | 0.030 |
Why?
| Monitoring, Physiologic | 1 | 2018 | 265 | 0.030 |
Why?
| Analysis of Variance | 1 | 1999 | 1283 | 0.030 |
Why?
| Organ Size | 1 | 1997 | 446 | 0.030 |
Why?
| Culture Media | 1 | 1996 | 168 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2023 | 2668 | 0.030 |
Why?
| Cyclic AMP | 1 | 1996 | 230 | 0.030 |
Why?
| Xenopus | 1 | 2015 | 84 | 0.030 |
Why?
| Sampling Studies | 1 | 2015 | 95 | 0.030 |
Why?
| Embryonic Induction | 1 | 1995 | 31 | 0.030 |
Why?
| Respiratory Insufficiency | 1 | 1999 | 316 | 0.030 |
Why?
| Hospitals, Pediatric | 1 | 2019 | 518 | 0.030 |
Why?
| Mice | 3 | 2019 | 16543 | 0.030 |
Why?
| Principal Component Analysis | 1 | 2015 | 185 | 0.030 |
Why?
| Laminin | 1 | 1995 | 70 | 0.030 |
Why?
| Mouth | 1 | 2015 | 81 | 0.030 |
Why?
| Vimentin | 1 | 1995 | 50 | 0.030 |
Why?
| Autophagy-Related Protein 8 Family | 1 | 2014 | 2 | 0.030 |
Why?
| Health Services Research | 1 | 2018 | 392 | 0.030 |
Why?
| Long-Term Care | 1 | 2015 | 88 | 0.030 |
Why?
| Demography | 1 | 2015 | 280 | 0.030 |
Why?
| Ventilator-Induced Lung Injury | 1 | 2015 | 57 | 0.030 |
Why?
| Proteostasis Deficiencies | 1 | 2014 | 6 | 0.030 |
Why?
| Sequestosome-1 Protein | 1 | 2014 | 13 | 0.030 |
Why?
| Vacuoles | 1 | 2014 | 36 | 0.030 |
Why?
| Hepatocyte Growth Factor | 1 | 1994 | 34 | 0.030 |
Why?
| Gene Expression Regulation | 2 | 2014 | 2520 | 0.030 |
Why?
| Proteoglycans | 1 | 1995 | 108 | 0.030 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2014 | 65 | 0.030 |
Why?
| North America | 1 | 2015 | 289 | 0.030 |
Why?
| Prevalence | 2 | 2011 | 2540 | 0.030 |
Why?
| Magnetic Resonance Imaging, Cine | 1 | 2015 | 181 | 0.030 |
Why?
| Fatal Outcome | 2 | 2009 | 301 | 0.030 |
Why?
| Mesoderm | 1 | 1995 | 139 | 0.030 |
Why?
| Persistent Fetal Circulation Syndrome | 1 | 2015 | 137 | 0.030 |
Why?
| Quality of Health Care | 1 | 2019 | 610 | 0.030 |
Why?
| ROC Curve | 1 | 2015 | 500 | 0.030 |
Why?
| Culture Techniques | 1 | 1994 | 82 | 0.030 |
Why?
| Drug Combinations | 1 | 1995 | 327 | 0.030 |
Why?
| Lysosomes | 1 | 2014 | 139 | 0.030 |
Why?
| Cardiovascular Agents | 1 | 2015 | 155 | 0.030 |
Why?
| rab GTP-Binding Proteins | 1 | 2014 | 73 | 0.030 |
Why?
| Embryonic and Fetal Development | 1 | 1994 | 95 | 0.030 |
Why?
| Consanguinity | 1 | 2013 | 47 | 0.030 |
Why?
| Microfilament Proteins | 1 | 2014 | 130 | 0.030 |
Why?
| B-Lymphocytes | 1 | 2019 | 813 | 0.030 |
Why?
| Rats, Inbred F344 | 3 | 2000 | 251 | 0.030 |
Why?
| Genes, Recessive | 1 | 2013 | 75 | 0.030 |
Why?
| Amino Acid Substitution | 1 | 2014 | 281 | 0.030 |
Why?
| Hydroxychloroquine | 1 | 2013 | 57 | 0.030 |
Why?
| Drainage | 1 | 2014 | 162 | 0.030 |
Why?
| Microtubule-Associated Proteins | 1 | 2014 | 182 | 0.030 |
Why?
| Radiography, Thoracic | 1 | 2014 | 162 | 0.030 |
Why?
| In Vitro Techniques | 1 | 1995 | 1061 | 0.030 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2014 | 155 | 0.030 |
Why?
| Azithromycin | 1 | 2013 | 92 | 0.030 |
Why?
| Laparoscopy | 1 | 1997 | 452 | 0.030 |
Why?
| Transcriptome | 1 | 2019 | 871 | 0.030 |
Why?
| Siblings | 1 | 2013 | 220 | 0.030 |
Why?
| Collagen | 1 | 1995 | 433 | 0.030 |
Why?
| Hernias, Diaphragmatic, Congenital | 1 | 2015 | 204 | 0.030 |
Why?
| Maternal-Fetal Exchange | 1 | 1994 | 159 | 0.030 |
Why?
| Middle Aged | 2 | 2019 | 30977 | 0.020 |
Why?
| Mice, Knockout | 1 | 2019 | 2770 | 0.020 |
Why?
| Pregnancy | 2 | 2015 | 6247 | 0.020 |
Why?
| Extracorporeal Membrane Oxygenation | 1 | 2015 | 281 | 0.020 |
Why?
| Pain, Postoperative | 1 | 2014 | 227 | 0.020 |
Why?
| Stem Cell Transplantation | 1 | 2013 | 167 | 0.020 |
Why?
| HEK293 Cells | 1 | 2014 | 673 | 0.020 |
Why?
| Pandemics | 1 | 2020 | 1516 | 0.020 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 395 | 0.020 |
Why?
| Algorithms | 2 | 2015 | 1626 | 0.020 |
Why?
| Congresses as Topic | 1 | 2013 | 217 | 0.020 |
Why?
| Dexamethasone | 1 | 1994 | 330 | 0.020 |
Why?
| Denmark | 1 | 2011 | 44 | 0.020 |
Why?
| Risk Factors | 2 | 2015 | 9792 | 0.020 |
Why?
| Laryngostenosis | 1 | 2011 | 28 | 0.020 |
Why?
| T-Lymphocytes | 1 | 2019 | 1905 | 0.020 |
Why?
| Granuloma | 1 | 2011 | 88 | 0.020 |
Why?
| Cells, Cultured | 2 | 1995 | 4048 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2015 | 1194 | 0.020 |
Why?
| Mice, Transgenic | 1 | 2015 | 2073 | 0.020 |
Why?
| Nitric Oxide | 1 | 2015 | 892 | 0.020 |
Why?
| Pilot Projects | 1 | 2015 | 1545 | 0.020 |
Why?
| Cell Line | 1 | 2015 | 2759 | 0.020 |
Why?
| Extracellular Matrix | 1 | 2014 | 493 | 0.020 |
Why?
| Chromosomes, Human, Pair 2 | 1 | 2009 | 28 | 0.020 |
Why?
| Chromosomes, Human, Pair 16 | 1 | 2009 | 31 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 2019 | 5270 | 0.020 |
Why?
| Mitochondria | 1 | 2014 | 837 | 0.020 |
Why?
| Specific Pathogen-Free Organisms | 2 | 2000 | 60 | 0.020 |
Why?
| DNA Methylation | 1 | 2013 | 600 | 0.020 |
Why?
| Time Factors | 1 | 2019 | 6568 | 0.020 |
Why?
| Genes, rRNA | 1 | 2007 | 41 | 0.020 |
Why?
| Biomedical Research | 1 | 2014 | 654 | 0.020 |
Why?
| Endocrine System Diseases | 1 | 2007 | 32 | 0.020 |
Why?
| Genes, Bacterial | 1 | 2007 | 159 | 0.020 |
Why?
| Growth Disorders | 1 | 2007 | 78 | 0.020 |
Why?
| Risk Assessment | 1 | 2015 | 3286 | 0.020 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 985 | 0.020 |
Why?
| Chronic Disease | 1 | 2011 | 1715 | 0.010 |
Why?
| Nervous System Diseases | 1 | 2007 | 260 | 0.010 |
Why?
| Postoperative Complications | 1 | 2015 | 2494 | 0.010 |
Why?
| CD-ROM | 1 | 2003 | 6 | 0.010 |
Why?
| Teaching Materials | 1 | 2003 | 24 | 0.010 |
Why?
| Signal Transduction | 1 | 1996 | 4857 | 0.010 |
Why?
| Proteins | 2 | 2000 | 945 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2007 | 2842 | 0.010 |
Why?
| Inflammation | 1 | 2014 | 2694 | 0.010 |
Why?
| Transplantation, Autologous | 1 | 2003 | 214 | 0.010 |
Why?
| Korea | 1 | 2001 | 10 | 0.010 |
Why?
| Statistics, Nonparametric | 1 | 2003 | 424 | 0.010 |
Why?
| Adenovirus Infections, Human | 1 | 2001 | 14 | 0.010 |
Why?
| Pneumonia, Mycoplasma | 1 | 2001 | 54 | 0.010 |
Why?
| Bromodeoxyuridine | 1 | 2000 | 77 | 0.010 |
Why?
| Pulmonary Surfactant-Associated Protein A | 1 | 2000 | 34 | 0.010 |
Why?
| In Situ Hybridization | 1 | 2000 | 295 | 0.010 |
Why?
| Acantholysis | 1 | 1999 | 2 | 0.010 |
Why?
| Castleman Disease | 1 | 1999 | 12 | 0.010 |
Why?
| Neoplasm Staging | 1 | 2003 | 1285 | 0.010 |
Why?
| Internet | 1 | 2003 | 616 | 0.010 |
Why?
| Epithelium | 1 | 1999 | 312 | 0.010 |
Why?
| Lymphoma, B-Cell | 1 | 1999 | 102 | 0.010 |
Why?
| Adolescent Behavior | 1 | 2003 | 498 | 0.010 |
Why?
| Phospholipases A | 1 | 1997 | 100 | 0.010 |
Why?
| Clinical Protocols | 1 | 1998 | 255 | 0.010 |
Why?
| Physical Examination | 1 | 1998 | 237 | 0.010 |
Why?
| Cell Count | 1 | 1996 | 316 | 0.010 |
Why?
| Influenza, Human | 1 | 2001 | 603 | 0.010 |
Why?
| Attitude of Health Personnel | 1 | 2002 | 1090 | 0.010 |
Why?
| Immunoglobulin G | 1 | 1999 | 834 | 0.010 |
Why?
| Proto-Oncogene Proteins c-met | 1 | 1994 | 75 | 0.010 |
Why?
| Age Factors | 1 | 2000 | 3133 | 0.010 |
Why?
|
|
Deterding's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|